• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Neil de Crescenzo Discusses New Oracle® Health Sciences Cloud

by Fred Pennic 05/24/2011 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences Global Business Unit, discusses how the new Oracle Health Sciences Cloud supports the increasingly networked environment for research, clinical development, and healthcare delivery in the healthcare and life sciences market.


Facts:

 Oracle Health Sciences Cloud Applications will be powered by the next-generation Oracle® Health Sciences Cloud, a scalable and secure software-as-a-service delivery platform tailored for the specific requirements and regulations of the health sciences market.
The enhanced Oracle Health Sciences Cloud delivers life sciences and healthcare applications with unparalleled performance, scalability and security. It supports the increasingly networked environment for research, clinical development, and healthcare delivery wherein data must be effectively and securely managed across multiple organizations, including life sciences companies, contract research organizations (CROs), academic medical centers, and regulators and outsourcing vendors.
In conjunction with Oracle Health Sciences Cloud Applications, Oracle Health Sciences Cloud will help health sciences organizations further accelerate IT deployments, reduce resources required to maintain IT infrastructure and gain a more predictable IT spending pattern.
Oracle Health Sciences Cloud is developed and rigorously tested for the specific security and privacy requirements of the health sciences industry. This HIPAA certified cloud provides full qualification and validation testing for each instance of the deployed application and is compliant with U.S. Food & Drug Administration (FDA) 21 CFR Part 11.
Oracle Health Sciences solutions currently available as a service on the Oracle Health Sciences Cloud include electronic data capture, electronic patient reported outcomes, study design, coding and dictionary management, trial randomization and drug supply management, research clinic automation, as well as safety management and will expand over time.
The Oracle Health Sciences Cloud currently hosts over 3,800 application instances supporting hundreds of thousands of users and millions of transactions per day in more than 117 countries.
The new Oracle Health Sciences Cloud will take advantage of Oracle’s hardware and software, including Oracle Fusion Middleware, Oracle Exadata Database Machine, andOracle’s Sun ZFS Storage Appliance.
About Oracle
Oracle is the world’s most complete, open, and integrated business software and hardware systems company.  For more information about Oracle, please visit our Web site athttp://www.oracle.com.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |